Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Intensity Therapeutics, Inc. Common stock

INTS
Current price
3.1 USD +0.1 USD (+3.33%)
Last closed 3.39 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 44 070 080 USD
Yield for 12 month +18.77 %
1Y
3Y
5Y
10Y
15Y
INTS
21.11.2021 - 28.11.2021

Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs in the United States. Its lead product candidate includes INT230-6, which is in human clinical studies for the treatment of refractory solid tumors, such as soft tissue sarcoma which is in phase 3 trails; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut. Address: 1 Enterprise Drive, Shelton, CT, United States, 06484-4779

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-147 000 USD

Last Year

-179 037 USD

Current Quarter

-6 000 USD

Last Quarter

-6 000 USD

Key Figures INTS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM
PE Ratio
Return On Assets TTM -72.74 %
PEG Ratio
Return On Equity TTM -147.23 %
Wall Street Target Price 12 USD
Revenue TTM
Book Value 0.39 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.24 USD
Diluted Eps TTM -0.24 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics INTS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History INTS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio
Last Split Date 08.04.1996
Dividend Date

Stock Valuation INTS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -4.7208
Price Book MRQ 8.3636

Financials INTS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators INTS

For 52 weeks

2.01 USD 10.65 USD
50 Day MA 3.66 USD
Shares Short Prior Month 41 124
200 Day MA 4.28 USD
Short Ratio 2.77
Shares Short 44 277
Short Percent 0.44 %